Tobira Therapeutics
Industry: Company
DescriptionFounded: 2006 Parent organization: AllerganFeedbackDisclaimer Claim this knowledge panel Knowledge ResultSee outside Permanently closed Tobira Therapeutics, Inc. is recorded closed at this location. If it's incorrectly closed, please report it.Thanks for improving Google. We'll review your report about this location. Something went wrong. We were not able to submit the request.ReportTobira Therapeutics, Inc.WebsiteDirections Saved (0) Saved Save Biotechnology company in South San Francisco, California Address: 701 Gateway Blvd #300, South San Francisco, CA 94080 Phone: (650) 741-6625Website: : Place name: : : : Category: : :
Tobira Therapeutics List of Employees There's an exhaustive list of past and present employees! Get comprehensive information on the number of employees at Tobira Therapeutics. You can filter them based on skills, years of employment, job, education, department, and prior employment.
Tobira Therapeutics Salaries. You can even request information on how much does Tobira Therapeutics pay if you want to. Learn about salaries, pros and cons of working for Tobira Therapeutics directly from the past employees.
Find People by Employers You can rekindle an old relationship, reconnect with a long-lost friend, former boss, business acquaintance who might be useful in your new line of work. With our employee database, the possibilities are endless. All you have to do is type in a couple of keywords and we'll bring you the exact information you wanted!
30 Tobira Therapeutics employees in database. Find out everything there's to know about Tobira Therapeutics employees. We offer you a great deal of unbiased information from the internal database, personal records, and many other details that might be of interest to you.
Tobira Therapeutics Employees
Employee
Years
Job
Industry
Mark Menning Mark Menning's Tobira Therapeutics Experience September 2012 - March 2014
Job Managing Director at Nucleo Life Sciences
Industry Pharmaceuticals
Experience
Actera Pharmaceuticals April 2014 - Present
Nucleo Life Sciences February 2014 - Present
Tobira Therapeutics September 2012 - March 2014
Gilead Sciences March 2003 - September 2012
Amgen 2000 - 2003
DuPont Pharmaceuticals 1995 - 2000
Education
The Ohio State University
Chemical Engineering
University College Dublin
Chemical and Bioprocess Engineering
Actera Pharmaceuticals April 2014 - Present
Nucleo Life Sciences February 2014 - Present
Tobira Therapeutics September 2012 - March 2014
Gilead Sciences March 2003 - September 2012
Amgen 2000 - 2003
DuPont Pharmaceuticals 1995 - 2000
Education
The Ohio State University
Chemical Engineering
University College Dublin
Chemical and Bioprocess Engineering
Frank Zampella Frank Zampella's Tobira Therapeutics Experience April 2014 - May 2014
Job Interim Controller at PneumRx, Inc.
Industry Biotechnology
Experience
Tobira Therapeutics April 2014 - May 2014
Theravance, Inc. January 2014 - April 2014
PneumRx, Inc. June 2013 - October 2013
InterMune, Inc. September 2006 - October 2012
Perlegen Sciences January 2000 - August 2006
Genentech December 1986 - January 2000
Intel Corporation April 1978 - December 1986
Skills
Biotechnology, SEC filings, Sarbanes-Oxley Act, Pharmaceutical Industry, Lifesciences, Auditing, Due Diligence, Accounting, Financial Analysis, Start-ups, SAP, Mergers, ERP, Licensing, Risk Management, General Ledger, Finance, Financial Reporting, Great Plains Software, Internal Controls, US GAAP, Revenue Recognition, Account Reconciliation, Strategic Financial..., Project Management, Management, Cash Flow, Financial Modeling, Variance Analysis, Mergers & Acquisitions, Strategy, Financial Statements, Budgets, Cost Accounting
Education
Rider University 1965 — 1969
BS Commerce, Public Accounting, B
Tobira Therapeutics April 2014 - May 2014
Theravance, Inc. January 2014 - April 2014
PneumRx, Inc. June 2013 - October 2013
InterMune, Inc. September 2006 - October 2012
Perlegen Sciences January 2000 - August 2006
Genentech December 1986 - January 2000
Intel Corporation April 1978 - December 1986
Skills
Biotechnology, SEC filings, Sarbanes-Oxley Act, Pharmaceutical Industry, Lifesciences, Auditing, Due Diligence, Accounting, Financial Analysis, Start-ups, SAP, Mergers, ERP, Licensing, Risk Management, General Ledger, Finance, Financial Reporting, Great Plains Software, Internal Controls, US GAAP, Revenue Recognition, Account Reconciliation, Strategic Financial..., Project Management, Management, Cash Flow, Financial Modeling, Variance Analysis, Mergers & Acquisitions, Strategy, Financial Statements, Budgets, Cost Accounting
Education
Rider University 1965 — 1969
BS Commerce, Public Accounting, B
Dat Mac, MS Dat Mac, MS's Tobira Therapeutics Experience August 2012 - August 2013
Job Clinical Trial Manager (Consultant) at Dynavax Technologies
Industry Biotechnology
Experience
Dynavax Technologies September 2013 - Present
Tobira Therapeutics August 2012 - August 2013
JANSSEN Alzheimer Immunotherapy (Unit of J&J Company) June 2012 - August 2012
Genentech June 2010 - June 2012
Exelixis May 2009 - June 2010
Elan Pharmaceuticals April 2008 - December 2008
Amgen November 2006 - April 2008
Genentech November 2004 - November 2006
Stanford University Medical Center November 2001 - October 2004
Harvard University School of Public Health June 1998 - June 1999
Skills
Clinical Trial..., EDC, Oncology, GCP, IND, Clinical Trials, CRO, Clinical Data Management, Clinical Research, Clinical Development, CTMS, Clinical Monitoring, Neuroscience, FDA, Protocol Development, Therapeutic areas, SOP, Pharmaceuticals, Regulatory Submissions, ICH-GCP, Neurology, Pharmacovigilance, Sop, Protocol, Therapeutic Areas, Pharmaceutical Industry, Clinical Study Design, Biotechnology, Cancer, Phase I, Clinical Operations, Drug Development, Infectious Diseases, Hematology, Medical Writing
Education
Harvard University 1997 — 1999
MS, Public Health
University of California, Berkeley 1992 — 1997
BA
Dynavax Technologies September 2013 - Present
Tobira Therapeutics August 2012 - August 2013
JANSSEN Alzheimer Immunotherapy (Unit of J&J Company) June 2012 - August 2012
Genentech June 2010 - June 2012
Exelixis May 2009 - June 2010
Elan Pharmaceuticals April 2008 - December 2008
Amgen November 2006 - April 2008
Genentech November 2004 - November 2006
Stanford University Medical Center November 2001 - October 2004
Harvard University School of Public Health June 1998 - June 1999
Skills
Clinical Trial..., EDC, Oncology, GCP, IND, Clinical Trials, CRO, Clinical Data Management, Clinical Research, Clinical Development, CTMS, Clinical Monitoring, Neuroscience, FDA, Protocol Development, Therapeutic areas, SOP, Pharmaceuticals, Regulatory Submissions, ICH-GCP, Neurology, Pharmacovigilance, Sop, Protocol, Therapeutic Areas, Pharmaceutical Industry, Clinical Study Design, Biotechnology, Cancer, Phase I, Clinical Operations, Drug Development, Infectious Diseases, Hematology, Medical Writing
Education
Harvard University 1997 — 1999
MS, Public Health
University of California, Berkeley 1992 — 1997
BA
Anna Stolyarova Anna Stolyarova's Tobira Therapeutics Experience June 2015 - August 2015
Job MBA/MPH Candidate at Haas School of Business
Industry Management Consulting
Experience
Tobira Therapeutics June 2015 - August 2015
Velano Vascular, Inc. November 2014 - August 2015
Genentech June 2014 - February 2015
McKinsey & Company September 2011 - July 2013
MGTS / Higher School of Economics 2009 - 2010
Conquest 2006 - 2008
Skills
Business Analysis, Financial Modeling, Management consulting, Operational Excellence, Business Strategy, Management Consulting, Analytics, Business Process..., Financial Analysis, Strategic Planning, Management, Corporate Finance
Education
University of California, Berkeley, Haas School of Business 2013 — 2015
Master of Business Administration / Master of Public Health (MBA/MPH)
Lomonosov Moscow State University (MSU) 2000 — 2006
Master of Arts (MA), Economics
Tobira Therapeutics June 2015 - August 2015
Velano Vascular, Inc. November 2014 - August 2015
Genentech June 2014 - February 2015
McKinsey & Company September 2011 - July 2013
MGTS / Higher School of Economics 2009 - 2010
Conquest 2006 - 2008
Skills
Business Analysis, Financial Modeling, Management consulting, Operational Excellence, Business Strategy, Management Consulting, Analytics, Business Process..., Financial Analysis, Strategic Planning, Management, Corporate Finance
Education
University of California, Berkeley, Haas School of Business 2013 — 2015
Master of Business Administration / Master of Public Health (MBA/MPH)
Lomonosov Moscow State University (MSU) 2000 — 2006
Master of Arts (MA), Economics
Reynold Driz's Tobira Therapeutics Experience March 2008 - January 2012
Job Director, Clinical Operations at ContraVir Pharmaceuticals Inc.
Industry Biotechnology
Experience
ContraVir Pharmaceuticals Inc. June 2014 - Present
Delcath Systems, Inc August 2013 - May 2014
Tobira Therapeutics March 2008 - January 2012
Johnson & Johnson March 2007 - March 2008
Hoffmann-La Roche August 2006 - March 2007
Bristol-Myers Squibb Company January 2005 - May 2006
Novartis January 2001 - December 2004
PRA International July 2000 - December 2000
Merck January 2000 - July 2000
Anthra Pharmaceuticals June 1998 - December 1999
Skills
CRO, Lifesciences, CTMS, Cross-functional Team..., Regulatory Submissions, Clinical Trials, Leadership, Clinical Research, EDC, Clinical Operations, GCP
Education
Kean University 2004 — 2007
BA, Psychology
Middlesex County College 1993 — 1994
LPN, Nursing
School of Visual Arts 1989 — 1992
N/A, Fine Arts
ContraVir Pharmaceuticals Inc. June 2014 - Present
Delcath Systems, Inc August 2013 - May 2014
Tobira Therapeutics March 2008 - January 2012
Johnson & Johnson March 2007 - March 2008
Hoffmann-La Roche August 2006 - March 2007
Bristol-Myers Squibb Company January 2005 - May 2006
Novartis January 2001 - December 2004
PRA International July 2000 - December 2000
Merck January 2000 - July 2000
Anthra Pharmaceuticals June 1998 - December 1999
Skills
CRO, Lifesciences, CTMS, Cross-functional Team..., Regulatory Submissions, Clinical Trials, Leadership, Clinical Research, EDC, Clinical Operations, GCP
Education
Kean University 2004 — 2007
BA, Psychology
Middlesex County College 1993 — 1994
LPN, Nursing
School of Visual Arts 1989 — 1992
N/A, Fine Arts
Ian Clements Ian Clements's Tobira Therapeutics Experience July 2015 - Present
Job VP Investor Relations & Corporate Communications at Tobira Therapeutics
Industry Biotechnology
Experience
Tobira Therapeutics July 2015 - Present
Avanir Pharmaceuticals 2011 - June 2015
SEQUENOM 2009 - 2011
The Trout Group December 2005 - November 2008
Accelrys January 2001 - October 2005
Molecular Simulations April 1997 - December 2000
Boots Contract Manufacturing October 1995 - March 1997
Skills
Investor Relations, Spokesperson, Marketing Strategy, Crisis Communications, Due Diligence, Corporate Communications, Strategic Communications, Strategy, Mergers, Corporate Development, Venture Capital, Lifesciences, Public Relations, Project Management, Start-ups, Program Management, Management, Pharmaceutical Industry, Business Strategy, Product Launch, Mergers & Acquisitions, Biotechnology, Analyst Relations, Competitive Analysis, Market Research, Finance, Marketing, Commercialization, Competitive Intelligence, Investments, Life Sciences, Leadership, Global Marketing, Oncology
Education
The Open University 2000 — 2003
MBA, Business
University of Manchester 1991 — 1995
PhD, Chemistry
Staffordshire University 1987 — 1991
BSc, Chemistry
Tobira Therapeutics July 2015 - Present
Avanir Pharmaceuticals 2011 - June 2015
SEQUENOM 2009 - 2011
The Trout Group December 2005 - November 2008
Accelrys January 2001 - October 2005
Molecular Simulations April 1997 - December 2000
Boots Contract Manufacturing October 1995 - March 1997
Skills
Investor Relations, Spokesperson, Marketing Strategy, Crisis Communications, Due Diligence, Corporate Communications, Strategic Communications, Strategy, Mergers, Corporate Development, Venture Capital, Lifesciences, Public Relations, Project Management, Start-ups, Program Management, Management, Pharmaceutical Industry, Business Strategy, Product Launch, Mergers & Acquisitions, Biotechnology, Analyst Relations, Competitive Analysis, Market Research, Finance, Marketing, Commercialization, Competitive Intelligence, Investments, Life Sciences, Leadership, Global Marketing, Oncology
Education
The Open University 2000 — 2003
MBA, Business
University of Manchester 1991 — 1995
PhD, Chemistry
Staffordshire University 1987 — 1991
BSc, Chemistry
Carol L. Brosgart, MD Carol L. Brosgart, MD's Tobira Therapeutics Experience 2009 - Present
Job Senior Advisor on Science and Policy, VHAC at the CDC Foundation and the Division of Viral Hepatitis at CDC
Industry Hospital & Health Care
Experience
Dynavax Technologies September 2012 - Present
Viral Hepatitis Action Coalition, CDC Foundation and the Division of Viral Hepatitis, CDC January 2012 - Present
Astex January 2012 - Present
Theravance December 2011 - Present
Faces for the Future Coalition 2011 - Present
CDC/HRSA Federal Advisory Committee on HIV/AIDS, Viral Hepatitis, and STDs 2011 - Present
Tobira Therapeutics 2009 - Present
Hepatitis B Foundation 2009 - Present
Infectious Diseases Society of America (IDSA) 2009 - Present
San Francisco AIDS Foundation 2008 - Present
Skills
Non-profits, Public Health, Global Health, Healthcare, Clinical Research, Prevention, Policy, HCV, HBV, Program Development, Grants, Infectious Diseases, Public Policy, Drug Development, Clinical Development, Viral Hepatitis, Clinical Trials, Biotechnology, Lifesciences, Pharmaceutical Industry, Policy Analysis, Medicine, Epidemiology, Health Policy, Vaccines, Immunology, Science, Medical Affairs, HIV prevention, Virology, Preventive Medicine, Medical Education, International Health, Biostatistics, Drug Discovery, Biopharmaceuticals, Hospitals, Outcomes Research, Regulatory Submissions, Health Economics, Commercialization, Health Services Research, Treatment, Medical Writing, Cancer, Health Education, Oncology, Molecular Biology, Community Outreach, Nonprofits
Education
University of California, Berkeley 1987 — 1989
Preventive Medicine, Joint Program, UC Berkeley School of Public Health and State of CA DHHS
University of California, San Francisco - School of Medicine 1977 — 1978
Pediatric Residency
University of California, San Francisco - School of Medicine 1973 — 1977
MD
University of California, Berkeley 1969 — 1973
BS, Community Medicine
Dynavax Technologies September 2012 - Present
Viral Hepatitis Action Coalition, CDC Foundation and the Division of Viral Hepatitis, CDC January 2012 - Present
Astex January 2012 - Present
Theravance December 2011 - Present
Faces for the Future Coalition 2011 - Present
CDC/HRSA Federal Advisory Committee on HIV/AIDS, Viral Hepatitis, and STDs 2011 - Present
Tobira Therapeutics 2009 - Present
Hepatitis B Foundation 2009 - Present
Infectious Diseases Society of America (IDSA) 2009 - Present
San Francisco AIDS Foundation 2008 - Present
Skills
Non-profits, Public Health, Global Health, Healthcare, Clinical Research, Prevention, Policy, HCV, HBV, Program Development, Grants, Infectious Diseases, Public Policy, Drug Development, Clinical Development, Viral Hepatitis, Clinical Trials, Biotechnology, Lifesciences, Pharmaceutical Industry, Policy Analysis, Medicine, Epidemiology, Health Policy, Vaccines, Immunology, Science, Medical Affairs, HIV prevention, Virology, Preventive Medicine, Medical Education, International Health, Biostatistics, Drug Discovery, Biopharmaceuticals, Hospitals, Outcomes Research, Regulatory Submissions, Health Economics, Commercialization, Health Services Research, Treatment, Medical Writing, Cancer, Health Education, Oncology, Molecular Biology, Community Outreach, Nonprofits
Education
University of California, Berkeley 1987 — 1989
Preventive Medicine, Joint Program, UC Berkeley School of Public Health and State of CA DHHS
University of California, San Francisco - School of Medicine 1977 — 1978
Pediatric Residency
University of California, San Francisco - School of Medicine 1973 — 1977
MD
University of California, Berkeley 1969 — 1973
BS, Community Medicine
Cliff Sachs Cliff Sachs's Tobira Therapeutics Experience June 2008 - February 2009
Job Managing Consultant Quality, Regulatory and Compliance Practice at Tunnell Consulting, Inc.
Industry Pharmaceuticals
Experience
Tunnell Consulting, Inc. June 2015 - Present
Validant February 2010 - May 2015
PII March 2009 - November 2009
Tobira Therapeutics June 2008 - February 2009
Bristol-Myers Squibb June 1982 - February 2008
Bristol-Myers Squibb 1982 - 2008
Skills
Quality Assurance, Quality Systems, Quality Management, Document Management, Information Management, Investigations, CAPA, Business Process..., Change Management, Private Investigations, Quality System, FDA, GMP, V&V, Quality Control, Validation, Testing, Change Control, Trackwise, Pharmaceutics, GLP, Drug Development, Quality Auditing, Sop, Software Documentation, LIMS, 21 CFR Part 11, R&D, Computer System..., GCP, IND, Formulation, Cleaning Validation, GxP, Technology Transfer, Regulatory Affairs, GAMP, Biopharmaceuticals, SOP, Pharmaceutical Industry, TrackWise
Education
Fairleigh Dickinson University 1983 — 1987
MBA, Pharmaceutical/Chemical Studies
Binghamton University 1978 — 1982
B.S., Chemistry
Ramapo Senior High School
Tunnell Consulting, Inc. June 2015 - Present
Validant February 2010 - May 2015
PII March 2009 - November 2009
Tobira Therapeutics June 2008 - February 2009
Bristol-Myers Squibb June 1982 - February 2008
Bristol-Myers Squibb 1982 - 2008
Skills
Quality Assurance, Quality Systems, Quality Management, Document Management, Information Management, Investigations, CAPA, Business Process..., Change Management, Private Investigations, Quality System, FDA, GMP, V&V, Quality Control, Validation, Testing, Change Control, Trackwise, Pharmaceutics, GLP, Drug Development, Quality Auditing, Sop, Software Documentation, LIMS, 21 CFR Part 11, R&D, Computer System..., GCP, IND, Formulation, Cleaning Validation, GxP, Technology Transfer, Regulatory Affairs, GAMP, Biopharmaceuticals, SOP, Pharmaceutical Industry, TrackWise
Education
Fairleigh Dickinson University 1983 — 1987
MBA, Pharmaceutical/Chemical Studies
Binghamton University 1978 — 1982
B.S., Chemistry
Ramapo Senior High School
Helen Jenkins Helen Jenkins's Tobira Therapeutics Experience 2011 - Present
Job Chief Operating Officer at Tobira Therapeutics
Industry Biotechnology
Experience
Tobira Therapeutics 2011 - Present
Nuon Therapeutics, Inc January 2007 - January 2011
Saegis Pharmacueticals, Inc. March 2000 - January 2007
Valentis June 1994 - January 2000
Glycomed Inc. May 1993 - July 1994
Genentech July 1985 - May 1993
Skills
Biotechnology, Strategic Planning, Drug Development, Operations Management, Project Portfolio..., Project Management, Start-ups, Clinical Development, Pharmaceutical Industry, Immunology, Strategy, GMP, Biopharmaceuticals, Technology Transfer, Program Management, Pharmacology, Lifesciences, Neuroscience, CRO, Biomarkers, Regulatory Requirements, IND, Oncology, Drug Discovery
Education
California Polytechnic State University-San Luis Obispo 1981 — 1985
BS, Biochemistry
San Francisco State University 1986 — 1989
MA, Molecular and Cellular Biology
Tobira Therapeutics 2011 - Present
Nuon Therapeutics, Inc January 2007 - January 2011
Saegis Pharmacueticals, Inc. March 2000 - January 2007
Valentis June 1994 - January 2000
Glycomed Inc. May 1993 - July 1994
Genentech July 1985 - May 1993
Skills
Biotechnology, Strategic Planning, Drug Development, Operations Management, Project Portfolio..., Project Management, Start-ups, Clinical Development, Pharmaceutical Industry, Immunology, Strategy, GMP, Biopharmaceuticals, Technology Transfer, Program Management, Pharmacology, Lifesciences, Neuroscience, CRO, Biomarkers, Regulatory Requirements, IND, Oncology, Drug Discovery
Education
California Polytechnic State University-San Luis Obispo 1981 — 1985
BS, Biochemistry
San Francisco State University 1986 — 1989
MA, Molecular and Cellular Biology
David Martin, PharmD, MBA David Martin, PharmD, MBA's Tobira Therapeutics Experience March 2009 - October 2011
Job Co Founder, Director and Chief Development Officer, DFH Pharma
Industry Pharmaceuticals
Experience
Evolv BioVet, Inc. September 2014 - Present
DFH Pharma, Inc. November 2011 - Present
Martin Pharma Consulting, LLC November 2011 - Present
Tobira Therapeutics March 2009 - October 2011
Panacos Pharmaceuticals, Inc. December 2001 - December 2008
DuPont Pharmaceuticals May 1999 - November 2001
PharmaResearch Corporation August 1997 - April 1999
GlaxoSmithKline 1994 - 1997
UNC Chapel Hill 1992 - 1994
Skills
Drug Development, Clinical Development, HIV/AIDS, Clinical Pharmacology, Clinical Trials, Clinical Trial..., Pharmacokinetics, Drug Discovery, Pre-clinical development, Research Project..., Regulatory Affairs, Fundraising, Board Level, Advisory Boards, Consultancy, Start-ups, Strategic Planning, Due Diligence, Project Management, FDA, CRO, CTMS, Pharmaceutical Industry, Biotechnology, Clinical Research, Regulatory Submissions, Infectious Diseases, IND, Biopharmaceuticals, Pharmaceutics, Lifesciences, Technology Transfer, Life Sciences, Consulting
Education
Saint Joseph's University - Erivan K. Haub School of Business 2000 — 2003
MBA
University of North Carolina at Chapel Hill 1992 — 1994
University of Southern California 1991 — 1992
PharmD
University of Southern California 1987 — 1991
PharmD
East Central University 1984 — 1987
Evolv BioVet, Inc. September 2014 - Present
DFH Pharma, Inc. November 2011 - Present
Martin Pharma Consulting, LLC November 2011 - Present
Tobira Therapeutics March 2009 - October 2011
Panacos Pharmaceuticals, Inc. December 2001 - December 2008
DuPont Pharmaceuticals May 1999 - November 2001
PharmaResearch Corporation August 1997 - April 1999
GlaxoSmithKline 1994 - 1997
UNC Chapel Hill 1992 - 1994
Skills
Drug Development, Clinical Development, HIV/AIDS, Clinical Pharmacology, Clinical Trials, Clinical Trial..., Pharmacokinetics, Drug Discovery, Pre-clinical development, Research Project..., Regulatory Affairs, Fundraising, Board Level, Advisory Boards, Consultancy, Start-ups, Strategic Planning, Due Diligence, Project Management, FDA, CRO, CTMS, Pharmaceutical Industry, Biotechnology, Clinical Research, Regulatory Submissions, Infectious Diseases, IND, Biopharmaceuticals, Pharmaceutics, Lifesciences, Technology Transfer, Life Sciences, Consulting
Education
Saint Joseph's University - Erivan K. Haub School of Business 2000 — 2003
MBA
University of North Carolina at Chapel Hill 1992 — 1994
University of Southern California 1991 — 1992
PharmD
University of Southern California 1987 — 1991
PharmD
East Central University 1984 — 1987
Craig Gibbs's Tobira Therapeutics Experience April 2014 - Present
Job Board Member at Tobira Therapeutics and Aridis Pharmaceuticals
Industry Biotechnology
Experience
Aridis Pharmaceuticals April 2015 - Present
Tobira Therapeutics April 2014 - Present
Gilead Sciences 2007 - 2013
Gilead Sciences January 2004 - January 2007
Gilead Sciences January 1998 - January 2004
Gilead Sciences January 1992 - 1998
Genentech Inc. January 1989 - 1992
Skills
Molecular Biology, Protein Engineering, Biotechnology, Drug Development, Clinical Development, Lifesciences, Drug Discovery, Pharmaceutical Industry, Oncology, Infectious Diseases, Biopharmaceuticals, Clinical Trials, Immunology, Commercialization, Virology, Pharmaceutical Sales, Protein Chemistry, Pharmacology, Inflammation, Biomarkers, Vaccines, Life Sciences
Education
University of Glasgow 1985 — 1988
Ph.D., Molecular Biology
Golden Gate University 2004 — 2006
M.B.A., Business Administration
Massey University 1981 — 1984
B.Sc.(Hons), Biochemistry
Rangitikei College
Aridis Pharmaceuticals April 2015 - Present
Tobira Therapeutics April 2014 - Present
Gilead Sciences 2007 - 2013
Gilead Sciences January 2004 - January 2007
Gilead Sciences January 1998 - January 2004
Gilead Sciences January 1992 - 1998
Genentech Inc. January 1989 - 1992
Skills
Molecular Biology, Protein Engineering, Biotechnology, Drug Development, Clinical Development, Lifesciences, Drug Discovery, Pharmaceutical Industry, Oncology, Infectious Diseases, Biopharmaceuticals, Clinical Trials, Immunology, Commercialization, Virology, Pharmaceutical Sales, Protein Chemistry, Pharmacology, Inflammation, Biomarkers, Vaccines, Life Sciences
Education
University of Glasgow 1985 — 1988
Ph.D., Molecular Biology
Golden Gate University 2004 — 2006
M.B.A., Business Administration
Massey University 1981 — 1984
B.Sc.(Hons), Biochemistry
Rangitikei College
Pierre Legault's Tobira Therapeutics Experience January 2015 - Present
Job CEO & President NephroGenex
Industry Pharmaceuticals
Experience
Iroko Pharmaceuticals, LLC April 2015 - Present
Tobira Therapeutics January 2015 - Present
NephroGenex October 2013 - Present
Forest Laboratories August 2012 - Present
Stone Management LLC April 2012 - Present
NPS Pharma November 2014 - April 2015
Regado Biosciences November 2013 - February 2015
NephroGenex November 2012 - November 2014
Prosidion Ltd. January 2011 - June 2012
OSI Pharmaceuticals December 2008 - January 2011
Education
McGill University 2005 — 2009
MBA
HEC Montréal 1979 — 1982
BAA, CA, Finance, Marketing & Accounting
Harvard Business School
Executive Master Program, Information Technology
Iroko Pharmaceuticals, LLC April 2015 - Present
Tobira Therapeutics January 2015 - Present
NephroGenex October 2013 - Present
Forest Laboratories August 2012 - Present
Stone Management LLC April 2012 - Present
NPS Pharma November 2014 - April 2015
Regado Biosciences November 2013 - February 2015
NephroGenex November 2012 - November 2014
Prosidion Ltd. January 2011 - June 2012
OSI Pharmaceuticals December 2008 - January 2011
Education
McGill University 2005 — 2009
MBA
HEC Montréal 1979 — 1982
BAA, CA, Finance, Marketing & Accounting
Harvard Business School
Executive Master Program, Information Technology
Anton Gopka's Tobira Therapeutics Experience December 2012 - May 2015
Job Entrepreneur & Venture Capitalist
Industry Venture Capital & Private Equity
Experience
ParaClassics June 2008 - Present
ATEM Capital July 2014 - Present
National Association of Corporate Directors December 2014 - Present
Skolkovo Foundation December 2014 - Present
Tobira Therapeutics December 2012 - May 2015
Marinus Pharmaceuticals December 2012 - April 2015
RUSNANO & Domain Associates Strategic Partnership May 2012 - October 2014
Atea Pharmaceuticals May 2014 - July 2014
NovaDigm Therapeutics September 2013 - July 2014
Tragara Pharmaceuticals August 2013 - July 2014
Skills
Corporate Finance, Mergers, IPO, Natural Resources, New Media, Strategic Advisory, Venture Capital, Private Equity, Strategy Development, Business Strategy, Financial Analysis, Investment Banking, Management Consulting, Start-ups, Business Analysis, Strategy, Investments, General Management, Management, Mergers & Acquisitions, Negotiation, Entrepreneurship, Valuation, International Business, Cross-functional Team..., Emerging Markets, Finance, Financial Structuring, Strategic Financial..., Managerial Finance, Restructuring, Financial Modeling, M&A experience, Investor Relations, Corporate Development, Capital Markets, Business Development, Asset Management, Risk Management, Strategic Planning, Financial Markets, Equities, Portfolio Management, Executive Management, Funding, Strategic Partnerships, New Business Development, Leadership, Project Finance
Education
Harvard Business School 2014 — 2014
Board Leadership
INSEAD 2008 — 2008
Corporate Finance
FSFR 2010 — 2010
Base Exam, 1.0, Corporate Finance and Regulation on the Russian Market
Licensed Business Valuation Course 2007 — 2007
Certificate, Business Valuation (Russian state official course)
CFA Institute 2005 — 2005
CFA Level I passed in 2005, Corporate Finance
Moscow State University for International Relations (MGIMO-University) 1999 — 2004
Master, International Financial Markets
ParaClassics June 2008 - Present
ATEM Capital July 2014 - Present
National Association of Corporate Directors December 2014 - Present
Skolkovo Foundation December 2014 - Present
Tobira Therapeutics December 2012 - May 2015
Marinus Pharmaceuticals December 2012 - April 2015
RUSNANO & Domain Associates Strategic Partnership May 2012 - October 2014
Atea Pharmaceuticals May 2014 - July 2014
NovaDigm Therapeutics September 2013 - July 2014
Tragara Pharmaceuticals August 2013 - July 2014
Skills
Corporate Finance, Mergers, IPO, Natural Resources, New Media, Strategic Advisory, Venture Capital, Private Equity, Strategy Development, Business Strategy, Financial Analysis, Investment Banking, Management Consulting, Start-ups, Business Analysis, Strategy, Investments, General Management, Management, Mergers & Acquisitions, Negotiation, Entrepreneurship, Valuation, International Business, Cross-functional Team..., Emerging Markets, Finance, Financial Structuring, Strategic Financial..., Managerial Finance, Restructuring, Financial Modeling, M&A experience, Investor Relations, Corporate Development, Capital Markets, Business Development, Asset Management, Risk Management, Strategic Planning, Financial Markets, Equities, Portfolio Management, Executive Management, Funding, Strategic Partnerships, New Business Development, Leadership, Project Finance
Education
Harvard Business School 2014 — 2014
Board Leadership
INSEAD 2008 — 2008
Corporate Finance
FSFR 2010 — 2010
Base Exam, 1.0, Corporate Finance and Regulation on the Russian Market
Licensed Business Valuation Course 2007 — 2007
Certificate, Business Valuation (Russian state official course)
CFA Institute 2005 — 2005
CFA Level I passed in 2005, Corporate Finance
Moscow State University for International Relations (MGIMO-University) 1999 — 2004
Master, International Financial Markets
Jay Rheingold's Tobira Therapeutics Experience 2008 - 2009
Job Pharmaceutical Development, Technology Transfer, Process Optimization, Validation, Quality Systems, Technical Writing
Industry Pharmaceuticals
Experience
scPharmaceuticals 2013 - Present
Drug Product Solutions 2009 - Present
Tobira Therapeutics 2008 - 2009
Barrier Therapeutics 2006 - 2008
Organon International 2004 - 2006
Organon USA Inc 1995 - 2004
Hoffmann-La Roche 1990 - 1994
Bristol-Myers Squibb 1987 - 1990
Lederle Laboratories 1979 - 1983
Education
State University of New York at Stony Brook
BS, Biology
The University of Connecticut
M.S., Ph.D., Pharmaceutical Sciences
scPharmaceuticals 2013 - Present
Drug Product Solutions 2009 - Present
Tobira Therapeutics 2008 - 2009
Barrier Therapeutics 2006 - 2008
Organon International 2004 - 2006
Organon USA Inc 1995 - 2004
Hoffmann-La Roche 1990 - 1994
Bristol-Myers Squibb 1987 - 1990
Lederle Laboratories 1979 - 1983
Education
State University of New York at Stony Brook
BS, Biology
The University of Connecticut
M.S., Ph.D., Pharmaceutical Sciences
Chris Peetz's Tobira Therapeutics Experience March 2014 - Present
Job Chief Financial Officer at Tobira Therapeutics
Industry Biotechnology
Experience
Tobira Therapeutics March 2014 - Present
Jennerex Biotherapeutics April 2012 - March 2014
Onyx Pharmaceuticals 2006 - April 2012
Onyx Pharmaceuticals 2006 - April 2012
Onyx Pharmaceuticals July 2006 - April 2008
Abgenix March 2005 - October 2005
ABN AMRO / LaSalle 2001 - 2004
Skills
Product Management, Medical Devices, Commercialization, Regulatory Affairs, Clinical Research, Business Strategy, Competitive Analysis, Biotechnology, Oncology, Strategy, Mergers & Acquisitions, Corporate Development, Lifesciences, Competitive Intelligence, Cross-functional Team..., Cancer, Pharmaceutical Industry, PowerPoint, Due Diligence, Entrepreneurship, Strategic Planning, Product Development, Biopharmaceuticals, Venture Capital, Valuation, Infectious Diseases, Global Marketing, Market Analysis, Drug Discovery, Start-ups, Technology Transfer, Marketing, Drug Development, Market Research, Clinical Trials, Intellectual Property, Negotiation, Licensing, Product Launch, Financial Modeling, Marketing Strategy, Clinical Development, Immunology, Analytics, Business Development, Finance, FDA, Strategic Partnerships, Product Marketing
Education
Stanford University Graduate School of Business 2004 — 2006
MBA
ESCP-EAP
Washington University in St. Louis
Tobira Therapeutics March 2014 - Present
Jennerex Biotherapeutics April 2012 - March 2014
Onyx Pharmaceuticals 2006 - April 2012
Onyx Pharmaceuticals 2006 - April 2012
Onyx Pharmaceuticals July 2006 - April 2008
Abgenix March 2005 - October 2005
ABN AMRO / LaSalle 2001 - 2004
Skills
Product Management, Medical Devices, Commercialization, Regulatory Affairs, Clinical Research, Business Strategy, Competitive Analysis, Biotechnology, Oncology, Strategy, Mergers & Acquisitions, Corporate Development, Lifesciences, Competitive Intelligence, Cross-functional Team..., Cancer, Pharmaceutical Industry, PowerPoint, Due Diligence, Entrepreneurship, Strategic Planning, Product Development, Biopharmaceuticals, Venture Capital, Valuation, Infectious Diseases, Global Marketing, Market Analysis, Drug Discovery, Start-ups, Technology Transfer, Marketing, Drug Development, Market Research, Clinical Trials, Intellectual Property, Negotiation, Licensing, Product Launch, Financial Modeling, Marketing Strategy, Clinical Development, Immunology, Analytics, Business Development, Finance, FDA, Strategic Partnerships, Product Marketing
Education
Stanford University Graduate School of Business 2004 — 2006
MBA
ESCP-EAP
Washington University in St. Louis
John Stockmal, PMP's Tobira Therapeutics Experience May 2008 - January 2009
Job Associate Director PRA Health SciencesMerck Embedded Team
Industry Pharmaceuticals
Experience
PRA Health Sciences September 2010 - Present
Merck June 2009 - October 2010
Tobira Therapeutics May 2008 - January 2009
Protalex April 2006 - May 2008
Novartis Pharma July 2001 - March 2006
Novartis May 2000 - June 2001
Schering-Plough Research Institute August 1999 - May 2000
Skills
Clinical Development, Drug Development, Program Management, Clinical Research, Project Management, Project Planning, Pharmaceutical Industry, Clinical Trials, CRO, CTMS, PMP, Sop, FDA, Biotechnology, GMP, Global Cross-Functional..., Resource Management, Qualitative and..., Strategic Financial..., IND, Biopharmaceuticals, EDC, SOP
Education
Villanova University 2007 — 2008
Masters Certification, Project Management
Michigan State University 1981 — 1985
BS, Biology
PRA Health Sciences September 2010 - Present
Merck June 2009 - October 2010
Tobira Therapeutics May 2008 - January 2009
Protalex April 2006 - May 2008
Novartis Pharma July 2001 - March 2006
Novartis May 2000 - June 2001
Schering-Plough Research Institute August 1999 - May 2000
Skills
Clinical Development, Drug Development, Program Management, Clinical Research, Project Management, Project Planning, Pharmaceutical Industry, Clinical Trials, CRO, CTMS, PMP, Sop, FDA, Biotechnology, GMP, Global Cross-Functional..., Resource Management, Qualitative and..., Strategic Financial..., IND, Biopharmaceuticals, EDC, SOP
Education
Villanova University 2007 — 2008
Masters Certification, Project Management
Michigan State University 1981 — 1985
BS, Biology
Pam Vig's Tobira Therapeutics Experience July 2015 - Present
Job VP, Clinical Research and Discovery at Tobira Therapeutics
Industry Biotechnology
Experience
Tobira Therapeutics July 2015 - Present
Presidio Pharmaceuticals, Inc. January 2010 - July 2015
Johnson & Johnnson April 2008 - June 2009
ViroPharma Incorporated 2007 - 2008
Idenix Pharmaceuticals 2006 - October 2007
Gilead Sciences 1999 - 2004
Chiron Corporation 1994 - 1998
Skills
Pharmaceutical Industry, Clinical Research, Lifesciences, Drug Development, Clinical Operations, Medical Affairs, Clinical Development, Biotechnology, Clinical Trials, Infectious Diseases, Therapeutic Areas, Oncology, CTMS, IND, Biopharmaceuticals, Life Sciences
Education
Imperial College London
PhD, Department of Hepatology
Tobira Therapeutics July 2015 - Present
Presidio Pharmaceuticals, Inc. January 2010 - July 2015
Johnson & Johnnson April 2008 - June 2009
ViroPharma Incorporated 2007 - 2008
Idenix Pharmaceuticals 2006 - October 2007
Gilead Sciences 1999 - 2004
Chiron Corporation 1994 - 1998
Skills
Pharmaceutical Industry, Clinical Research, Lifesciences, Drug Development, Clinical Operations, Medical Affairs, Clinical Development, Biotechnology, Clinical Trials, Infectious Diseases, Therapeutic Areas, Oncology, CTMS, IND, Biopharmaceuticals, Life Sciences
Education
Imperial College London
PhD, Department of Hepatology
Yvette G. Fantham's Tobira Therapeutics Experience September 2012 - March 2014
Job Independent Finance Consultant
Industry Biotechnology
Experience
Tobira Therapeutics September 2012 - March 2014
Poniard Pharmaceuticals August 2006 - February 2012
NeoRx June 2004 - August 2006
Pfizer; Pharmacia; Sugen, Inc. 1997 - 2004
Sugen, Inc. 1997 - 2004
Deloitte & Touche September 1992 - April 1997
Education
San Francisco State University 1987 — 1992
Accounting
Tobira Therapeutics September 2012 - March 2014
Poniard Pharmaceuticals August 2006 - February 2012
NeoRx June 2004 - August 2006
Pfizer; Pharmacia; Sugen, Inc. 1997 - 2004
Sugen, Inc. 1997 - 2004
Deloitte & Touche September 1992 - April 1997
Education
San Francisco State University 1987 — 1992
Accounting
Caroline Loewy's Tobira Therapeutics Experience September 2012 - February 2014
Job Principal at Financial and Strategic Consulting
Industry Biotechnology
Experience
Translational Genomics Research Institute (TGen) March 2015 - Present
Financial and Strategic Consulting February 2014 - Present
Slide Ranch April 2012 - Present
Global Genes/RARE Project June 2009 - Present
Tobira Therapeutics September 2012 - February 2014
Financial and Strategic Consulting July 2011 - September 2012
Poniard Pharmaceuticals May 2012 - August 2012
Golden Gate Regional Center June 2009 - May 2012
BayBio 2006 - December 2011
Corcept Therapeutics November 2008 - June 2011
Skills
Biotechnology, Venture Capital, Corporate Development, Mergers, Due Diligence, Pharmaceutical Industry, Investor Relations, Valuation, Strategic Planning, Financial Modeling, IPO, Lifesciences, Private Equity, Corporate Finance, Investments, Finance, Mergers & Acquisitions, Technology Transfer, Strategy, Entrepreneurship, Start-ups, Business Development, Executive Management, Commercialization, Equity Research, Emerging Markets, Life Sciences, Acquisition Integration, Competitive Analysis, M&A experience
Education
Carnegie Mellon University 1988 — 1990
MBA, Finance
Carnegie Mellon University - Tepper School of Business 1988 — 1990
MBA, Finance
University of California, Berkeley 1983 — 1988
BA, Economics/Microbiology
Translational Genomics Research Institute (TGen) March 2015 - Present
Financial and Strategic Consulting February 2014 - Present
Slide Ranch April 2012 - Present
Global Genes/RARE Project June 2009 - Present
Tobira Therapeutics September 2012 - February 2014
Financial and Strategic Consulting July 2011 - September 2012
Poniard Pharmaceuticals May 2012 - August 2012
Golden Gate Regional Center June 2009 - May 2012
BayBio 2006 - December 2011
Corcept Therapeutics November 2008 - June 2011
Skills
Biotechnology, Venture Capital, Corporate Development, Mergers, Due Diligence, Pharmaceutical Industry, Investor Relations, Valuation, Strategic Planning, Financial Modeling, IPO, Lifesciences, Private Equity, Corporate Finance, Investments, Finance, Mergers & Acquisitions, Technology Transfer, Strategy, Entrepreneurship, Start-ups, Business Development, Executive Management, Commercialization, Equity Research, Emerging Markets, Life Sciences, Acquisition Integration, Competitive Analysis, M&A experience
Education
Carnegie Mellon University 1988 — 1990
MBA, Finance
Carnegie Mellon University - Tepper School of Business 1988 — 1990
MBA, Finance
University of California, Berkeley 1983 — 1988
BA, Economics/Microbiology
Michael Kamdar's Tobira Therapeutics Experience January 2008 - Present
Job President, Ciclofilin Pharmaceuticals
Industry Biotechnology
Experience
Ciclofilin Pharmaceuticals October 2014 - Present
Cellana LLC May 2013 - Present
Genoa Pharmaceuticals September 2011 - Present
Tobira Therapeutics January 2008 - Present
VentiRx Pharmaceuticals June 2006 - December 2011
Anadys Pharmaceuticals 2001 - 2005
Agouron Pharmaceuticals, A Pfizer Company 1993 - 2001
Education
Villanova University 1989 — 1991
MBA
Saint Joseph's University 1984 — 1988
BS, Biology
Ciclofilin Pharmaceuticals October 2014 - Present
Cellana LLC May 2013 - Present
Genoa Pharmaceuticals September 2011 - Present
Tobira Therapeutics January 2008 - Present
VentiRx Pharmaceuticals June 2006 - December 2011
Anadys Pharmaceuticals 2001 - 2005
Agouron Pharmaceuticals, A Pfizer Company 1993 - 2001
Education
Villanova University 1989 — 1991
MBA
Saint Joseph's University 1984 — 1988
BS, Biology
Julianne Pindar's Tobira Therapeutics Experience November 2008 - March 2009
Job Experienced Marketing Professional Looking for New Opportunity
Industry Marketing and Advertising
Experience
North Highlands for Merrill Lynch January 2011 - Present
Airwell Fedders North America March 2009 - March 2011
Tobira Therapeutics November 2008 - March 2009
Altlernative Mortgage & Investment Company April 2002 - October 2008
Merrill Lynch Global Diversity January 1999 - January 2001
Merrill Lynch Private Client Group January 1994 - January 1998
Merrill Lynch Private Client Group January 1986 - January 1993
Skills
Vendor Management, Project Management, Microsoft Excel, Marketing, Strategic Planning, Business Development, Visio, Management, Cross-functional Team..., Account Management, Process Improvement, Program Management, Team Leadership, Team Building, Marketing Communications, Department Budget..., Intranet, Web Site Editing, Coaching, Customer Service, Outlook, Marketing Strategy, Leadership, Budgets
Education
The College of New Jersey 1990 — 1996
Bachelor's of Science, Marketing
Bucks County Community College 1983 — 1989
Associates Degree, Business Administration
North Highlands for Merrill Lynch January 2011 - Present
Airwell Fedders North America March 2009 - March 2011
Tobira Therapeutics November 2008 - March 2009
Altlernative Mortgage & Investment Company April 2002 - October 2008
Merrill Lynch Global Diversity January 1999 - January 2001
Merrill Lynch Private Client Group January 1994 - January 1998
Merrill Lynch Private Client Group January 1986 - January 1993
Skills
Vendor Management, Project Management, Microsoft Excel, Marketing, Strategic Planning, Business Development, Visio, Management, Cross-functional Team..., Account Management, Process Improvement, Program Management, Team Leadership, Team Building, Marketing Communications, Department Budget..., Intranet, Web Site Editing, Coaching, Customer Service, Outlook, Marketing Strategy, Leadership, Budgets
Education
The College of New Jersey 1990 — 1996
Bachelor's of Science, Marketing
Bucks County Community College 1983 — 1989
Associates Degree, Business Administration
Eric Lefebvre's Tobira Therapeutics Experience January 2012 - Present
Job Chief Medical Officer at Tobira Therapeutics
Industry Biotechnology
Experience
Tobira Therapeutics January 2012 - Present
JJPS January 2007 - December 2011
Johnson & Johnson April 2003 - December 2006
GlaxoSmithKline August 2001 - April 2003
Clinique médicale l'Actuel March 1989 - March 2003
Skills
Oncology, CTMS, Medical Writing, Gastroenterology, Clinical Development, Therapeutic Areas, Healthcare, Vaccines, Commercialization, Medicine, Drug Discovery, Immunology, Neurology, Cancer, Biotechnology, Hematology, GCP
Education
University of Montreal 1982 — 1987
Doctor of Medicine (M.D.)
College Edouard Montpetit 1980 — 1982
Bachelor of Science (B.S.)
Tobira Therapeutics January 2012 - Present
JJPS January 2007 - December 2011
Johnson & Johnson April 2003 - December 2006
GlaxoSmithKline August 2001 - April 2003
Clinique médicale l'Actuel March 1989 - March 2003
Skills
Oncology, CTMS, Medical Writing, Gastroenterology, Clinical Development, Therapeutic Areas, Healthcare, Vaccines, Commercialization, Medicine, Drug Discovery, Immunology, Neurology, Cancer, Biotechnology, Hematology, GCP
Education
University of Montreal 1982 — 1987
Doctor of Medicine (M.D.)
College Edouard Montpetit 1980 — 1982
Bachelor of Science (B.S.)
Andrew McKibben's Tobira Therapeutics Experience December 2014 - Present
Job Finance and Corporate Development
Industry Biotechnology
Experience
Tobira Therapeutics December 2014 - Present
Tobira Therapeutics May 2014 - December 2014
Onyx Pharmaceuticals May 2011 - April 2014
Deloitte Consulting August 2005 - June 2010
Skills
Strategy, Business Strategy, Competitive Analysis, Mergers & Acquisitions, Financial Modeling, Financial Analysis, Management Consulting, Valuation, Due Diligence, Corporate Development, Venture Capital, Emerging Markets, Entrepreneurship, Business Process..., Organizational Design, Product Management, Lifesciences, Acquisition Integration, Market Research, Market Analysis, Analysis, Data Analysis, Biotechnology, Business Development, Project Management, Pharmaceutical Industry, Start-ups, Corporate Finance, Program Management, Analytics, Strategic Planning, Cross-functional Team...
Education
Pomona College
French Literature, Economics
University of California, Berkeley, Haas School of Business
Master of Business Administration (M.B.A.)
Tobira Therapeutics December 2014 - Present
Tobira Therapeutics May 2014 - December 2014
Onyx Pharmaceuticals May 2011 - April 2014
Deloitte Consulting August 2005 - June 2010
Skills
Strategy, Business Strategy, Competitive Analysis, Mergers & Acquisitions, Financial Modeling, Financial Analysis, Management Consulting, Valuation, Due Diligence, Corporate Development, Venture Capital, Emerging Markets, Entrepreneurship, Business Process..., Organizational Design, Product Management, Lifesciences, Acquisition Integration, Market Research, Market Analysis, Analysis, Data Analysis, Biotechnology, Business Development, Project Management, Pharmaceutical Industry, Start-ups, Corporate Finance, Program Management, Analytics, Strategic Planning, Cross-functional Team...
Education
Pomona College
French Literature, Economics
University of California, Berkeley, Haas School of Business
Master of Business Administration (M.B.A.)
Ericka Goss's Tobira Therapeutics Experience May 2015 - July 2015
Job Accounting Manager at Regado Biosciences, Inc.
Industry Accounting
Experience
Tobira Therapeutics May 2015 - July 2015
Regado Biosciences, Inc. November 2008 - May 2015
AICPA February 2007 - October 2008
The EI Group, Inc. 2002 - 2007
Skills
Financial Reporting, Budgets, Accounting, Financial Accounting, Financial Analysis, Accounts Receivable, General Ledger, Revenue Recognition, Internal Controls, US GAAP, CPA, Financial Statements
Education
Michigan State University 1992 — 1996
Bachelor of Arts (B.A.), Accounting
Tobira Therapeutics May 2015 - July 2015
Regado Biosciences, Inc. November 2008 - May 2015
AICPA February 2007 - October 2008
The EI Group, Inc. 2002 - 2007
Skills
Financial Reporting, Budgets, Accounting, Financial Accounting, Financial Analysis, Accounts Receivable, General Ledger, Revenue Recognition, Internal Controls, US GAAP, CPA, Financial Statements
Education
Michigan State University 1992 — 1996
Bachelor of Arts (B.A.), Accounting
Patrick Heron's Tobira Therapeutics Experience September 2007 - Present
Job General Partner at Frazier Healthcare
Industry Venture Capital & Private Equity
Experience
Calibrium December 2013 - Present
Silvergate Pharmaceuticals June 2011 - Present
Precision Dermatology June 2010 - Present
Collegium Pharmaceutical June 2008 - Present
Tobira Therapeutics September 2007 - Present
VentiRx Pharmaceuticals June 2007 - Present
QuatRx June 2000 - Present
Frazier Healthcare August 1999 - Present
Moximed June 2013 - December 2014
Marcadia Biotech 2006 - 2010
Skills
Private Equity, Mergers, Valuation, Venture Capital, Strategic Partnerships, Mergers & Acquisitions, Start-ups, Due Diligence, Biotechnology, Corporate Development, Investments, Venture Financing, Healthcare, Investor Relations, Entrepreneurship, Financial Modeling, Strategy, Growth Capital, Angel Investing, Life Sciences
Education
Harvard Business School 1994 — 1996
MBA
University of North Carolina at Chapel Hill 1988 — 1992
BA, Political Science
Calibrium December 2013 - Present
Silvergate Pharmaceuticals June 2011 - Present
Precision Dermatology June 2010 - Present
Collegium Pharmaceutical June 2008 - Present
Tobira Therapeutics September 2007 - Present
VentiRx Pharmaceuticals June 2007 - Present
QuatRx June 2000 - Present
Frazier Healthcare August 1999 - Present
Moximed June 2013 - December 2014
Marcadia Biotech 2006 - 2010
Skills
Private Equity, Mergers, Valuation, Venture Capital, Strategic Partnerships, Mergers & Acquisitions, Start-ups, Due Diligence, Biotechnology, Corporate Development, Investments, Venture Financing, Healthcare, Investor Relations, Entrepreneurship, Financial Modeling, Strategy, Growth Capital, Angel Investing, Life Sciences
Education
Harvard Business School 1994 — 1996
MBA
University of North Carolina at Chapel Hill 1988 — 1992
BA, Political Science
Aaron Cozen's Tobira Therapeutics Experience April 2014 - Present
Job Assistant Project Scientist at UC Santa Cruz
Industry Higher Education
Experience
Tobira Therapeutics April 2014 - Present
UC Santa Cruz July 2012 - Present
UC Santa Cruz August 2009 - July 2012
The Gladstone Institutes November 1996 - June 2001
Skills
Molecular Biology, Genomics, RNA, Bioinformatics, Microbiology, Biotechnology, Research, Laboratory, Physiology
Education
UC Santa Cruz 2001 — 2008
Doctor of Philosophy (PhD), Ocean Sciences
UC Santa Cruz 1989 — 1993
Bachelor of Arts (BA), Biology
Tobira Therapeutics April 2014 - Present
UC Santa Cruz July 2012 - Present
UC Santa Cruz August 2009 - July 2012
The Gladstone Institutes November 1996 - June 2001
Skills
Molecular Biology, Genomics, RNA, Bioinformatics, Microbiology, Biotechnology, Research, Laboratory, Physiology
Education
UC Santa Cruz 2001 — 2008
Doctor of Philosophy (PhD), Ocean Sciences
UC Santa Cruz 1989 — 1993
Bachelor of Arts (BA), Biology
Martine Kraus's Tobira Therapeutics Experience January 2012 - May 2015
Job Vice President, Regulatory Affairs and Quality Assurance at Global Blood Therapeutics
Industry Biotechnology
Experience
Global Blood Therapeutics June 2015 - Present
Tobira Therapeutics January 2012 - May 2015
Gilead Sciences June 2007 - December 2011
Gilead Sciences February 2002 - June 2007
Gilead Sciences February 2000 - February 2002
ALZA Corporation October 1996 - February 2000
Skills
IND, Clinical Development, Biotechnology, Regulatory Affairs, Regulatory Requirements, Regulatory Submissions, Regulatory Strategy, Promotional Compliance, Advertising and..., Labeling, NDA, MAA, International..., Postmarketing..., FDA, EMA, eCTD, GCP, Drug Development, Oncology, Clinical Trials
Education
University of California, Berkeley
PhD
University of Sussex, United Kingdom
Graduate Studies
University of Toulouse, France
BA & MA
Global Blood Therapeutics June 2015 - Present
Tobira Therapeutics January 2012 - May 2015
Gilead Sciences June 2007 - December 2011
Gilead Sciences February 2002 - June 2007
Gilead Sciences February 2000 - February 2002
ALZA Corporation October 1996 - February 2000
Skills
IND, Clinical Development, Biotechnology, Regulatory Affairs, Regulatory Requirements, Regulatory Submissions, Regulatory Strategy, Promotional Compliance, Advertising and..., Labeling, NDA, MAA, International..., Postmarketing..., FDA, EMA, eCTD, GCP, Drug Development, Oncology, Clinical Trials
Education
University of California, Berkeley
PhD
University of Sussex, United Kingdom
Graduate Studies
University of Toulouse, France
BA & MA
Jeffrey Enejosa, MD's Tobira Therapeutics Experience 2012 - 2013
Job Medical Director, Infectious Disease Development at AbbVie
Industry Pharmaceuticals
Experience
AbbVie 2013 - Present
Tobira Therapeutics 2012 - 2013
Dynavax Technologies 2011 - 2012
Desert AIDS Project 2009 - 2011
Gilead Sciences 2003 - 2009
Callen-Lorde Community Health Center 2002 - 2003
Bristol-Myers Squibb 2000 - 2002
Private Practice in Fort Lauderdale, FL 1996 - 2000
Union General Hospital 1994 - 1996
New York Medical College 1993 - 1994
Skills
Clinical Development, Clinical Trials, Infectious Diseases, Medical Writing, Pharmacovigilance, Immunology, Biotechnology, Medical Affairs, GCP, Clinical Research, Drug Safety, Drug Development, Medicine, CTMS, Oncology, IND, Therapeutic Areas, CRO, Clinical Monitoring, Regulatory Submissions
Education
New York Medical College
Post-Graduate, Internal Medicine
Philippine Science High School
HS Diploma
University of the Philippines
MD, Doctor of Medicine
University of the Philippines
BS Basic Medical Sciences
AbbVie 2013 - Present
Tobira Therapeutics 2012 - 2013
Dynavax Technologies 2011 - 2012
Desert AIDS Project 2009 - 2011
Gilead Sciences 2003 - 2009
Callen-Lorde Community Health Center 2002 - 2003
Bristol-Myers Squibb 2000 - 2002
Private Practice in Fort Lauderdale, FL 1996 - 2000
Union General Hospital 1994 - 1996
New York Medical College 1993 - 1994
Skills
Clinical Development, Clinical Trials, Infectious Diseases, Medical Writing, Pharmacovigilance, Immunology, Biotechnology, Medical Affairs, GCP, Clinical Research, Drug Safety, Drug Development, Medicine, CTMS, Oncology, IND, Therapeutic Areas, CRO, Clinical Monitoring, Regulatory Submissions
Education
New York Medical College
Post-Graduate, Internal Medicine
Philippine Science High School
HS Diploma
University of the Philippines
MD, Doctor of Medicine
University of the Philippines
BS Basic Medical Sciences
Joseph Naranja's Tobira Therapeutics Experience August 2015 - Present
Job AP Specialist at Tobira Therapeutics
Industry Accounting
Experience
Tobira Therapeutics August 2015 - Present
Essex Property Trust June 2014 - July 2015
Robert Half International June 2013 - June 2014
Skills
Accounting, Microsoft Excel, Outlook, Microsoft Office, Microsoft Word, Data Entry, PowerPoint, Accounts Payable
Education
Golden Gate University 2010 — 2013
Bachelor of Science, Business
Tobira Therapeutics August 2015 - Present
Essex Property Trust June 2014 - July 2015
Robert Half International June 2013 - June 2014
Skills
Accounting, Microsoft Excel, Outlook, Microsoft Office, Microsoft Word, Data Entry, PowerPoint, Accounts Payable
Education
Golden Gate University 2010 — 2013
Bachelor of Science, Business
Deloitte
PwC
Ernst & Young
Walgreens
Procter & Gamble
KPMG
PricewaterhouseCoopers
EY